Indaptus Therapeutics, Inc. (INDP)
2.275
-0.32
(-12.16%)
USD |
NASDAQ |
Oct 07, 16:00
2.275
0.00 (0.00%)
After-Hours: 20:00
Indaptus Therapeutics Enterprise Value : 333.54M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 333.54M |
| October 05, 2026 | 322.88M |
| October 02, 2026 | 305.56M |
| October 01, 2026 | 270.92M |
| September 30, 2026 | 294.90M |
| September 29, 2026 | 368.19M |
| September 28, 2026 | 426.81M |
| September 25, 2026 | 501.43M |
| September 24, 2026 | 521.42M |
| September 23, 2026 | 490.77M |
| September 22, 2026 | 520.08M |
| September 21, 2026 | 400.16M |
| September 18, 2026 | 461.46M |
| September 17, 2026 | 512.09M |
| September 16, 2026 | 416.15M |
| September 15, 2026 | 473.45M |
| September 14, 2026 | 406.83M |
| September 11, 2026 | 357.53M |
| September 10, 2026 | 329.55M |
| September 09, 2026 | 265.59M |
| September 08, 2026 | 234.94M |
| September 04, 2026 | 151.00M |
| September 03, 2026 | 143.01M |
| September 02, 2026 | 144.34M |
| September 01, 2026 | 139.01M |
| Date | Value |
|---|---|
| August 31, 2026 | 141.01M |
| August 28, 2026 | 140.34M |
| August 27, 2026 | 143.01M |
| August 26, 2026 | 140.34M |
| August 25, 2026 | 134.35M |
| August 24, 2026 | 143.01M |
| August 21, 2026 | 160.33M |
| August 20, 2026 | 172.32M |
| August 19, 2026 | 113.69M |
| August 18, 2026 | 113.17M |
| August 17, 2026 | 121.69M |
| August 14, 2026 | 131.02M |
| August 13, 2026 | 129.68M |
| August 12, 2026 | 124.35M |
| August 11, 2026 | 147.00M |
| August 10, 2026 | 147.00M |
| August 07, 2026 | 145.67M |
| August 06, 2026 | 155.00M |
| August 05, 2026 | 165.66M |
| August 04, 2026 | 169.66M |
| August 03, 2026 | 162.99M |
| July 31, 2026 | 160.33M |
| July 30, 2026 | 180.32M |
| July 29, 2026 | 230.95M |
| July 28, 2026 | 218.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Capricor Therapeutics, Inc. | 303.46M |
| Cypherpunk Technologies, Inc. | 343.73M |
| Ocugen, Inc. | 340.54M |
| ACADIA Pharmaceuticals, Inc. | 2.515B |
| Alnylam Pharmaceuticals, Inc. | 29.63B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.795M |
| Total Expenses (Quarterly) | 1.795M |
| EPS Diluted (Quarterly) | -0.0155 |
| Earnings Yield | -306.6% |
| Normalized Earnings Yield | -294.13 |